Global Regenerative Medicine Market - Overview
The demand for biologically derived materials for regenerative medicine is currently high due to its efficiency over other naturally derived materials. During the surgical procedures, synthetic materials are more preferred as they provide better outcome. Increase in demand for material reengineering and cell biology with the recent progress in the design of synthetic materials have led to the use of hydrogel in the formation of tissue-engineered scaffolds.
Globally the regenerative medicine market size is expected to grow at the rate of about 25.4% from 2016 to 2022.
Numerous government bodies are encouraging the growing regenerative medicine market. For instance, National Institutes of Health (NIH) supports scientific research community through NIH Regenerative Medicine Program, International SC Research, and State Initiatives for Stem Cell Research, NIH SC Unit, NIH SC Libraries & Projects, and NIH SC Translation Laboratory.
However, identifying the potential clinical applications in countries such as U.S., UK, China, and Japan have introduced changes in their regulatory policies to encourage research. Thus, the industry is projected to reflect accelerated growth over the forecast period.
Industry Updates
October, 2017 Advanced Medical Solutions Group and Organogenesis Inc. enter into patent out-licensing agreement. The companies have agreed on the US patent on the collagen-based wound dressing containing Polyhexamethylene Biguanide
July, 2017 Baxter International Inc., a global medical products company announced the acquisition of Claris Injectables Limited. The acquisition is expected to broaden Baxter’s presence in the generic pharmaceuticals market and will boost the supply of essential medicines to the customers.
March, 2017 Organogenesis Inc. has acquired NuTech Medical. The newly-formed company has expanded product portfolio for the wound care and surgical biologics markets.
Organogenesis Inc. (U.S.), Osiris Therapeutics, Inc. (U.S.), Vericel Corporation (U.S.), Stryker Corporation (U.S.), NuVasive, Inc. (U.S.), Medtronic (Ireland), Acelity (KCI Concepts) (U.S.), Integra LifeSciences (U.S.), Cook Biotech Inc. (U.S.), C.R. Bard (U.S.), RTI surgical (U.S.), Baxter International, Inc. (U.S.), Advanced Cell Technology (U.S.), CryoLife (U.S.), Sanofi (France), BioMimetic Therapeutics (U.S.), StemCells Inc. (U.S.), LifeCell Kinetic Concepts (U.S.) and others are some of the prominent players at the forefront of competition in the global regenerative medicine market and are profiled in MRFR Analysis.
https://www.marketresearchfuture.com/reports/regenerative-medicine-market-2220